Pro Medicus, Ltd.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Semi-annual Revenue
•
in mil. unless spec.Semi-annual Earnings Per Share
•
in mil. unless spec.Semi-annual Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Sam Aaron Hupert
- Full Time Employees
- 153
- Sector
- Health services
- Industry
- Services to the health industry
- Address
- 450 Swan Street Richmond VIC Australia 3121
- IPO Date
- Sep 5, 2000
- Website
- promed.com.au
- Similar Companies
- Business
- Pro Medicus Limited (ASX:PME) is an Australia-based healthcare informatics company that develops and supplies medical imaging software and radiology information systems (RIS) to hospitals, imaging centers, and healthcare groups worldwide. The company offers a comprehensive suite of products and services, including Visage 7 Enterprise Imaging Platform, a cloud or on-premise solution providing ultrafast diagnostic imaging, clinical workflows, vendor-neutral archiving, and AI acceleration through its One Viewer philosophy; Visage RIS, featuring medical accounting, clinical reporting, appointment scheduling, and management information applications; Visage RIS/PACS for integrated radiology operations; and Visage Ease and Visage Ease Pro for mobile access to images and reports, including diagnostic capabilities; as well as services encompassing workflow optimization, network design, hardware configuration, staff training, and 24/7 support. Founded in 1983 and headquartered in Melbourne, Victoria, Pro Medicus operates primarily in Australia, North America, and Europe, with its wholly-owned subsidiary Visage Imaging delivering enterprise-scale PACS replacement solutions globally. In recent developments, the company reported full-year 2025 revenue of A$213.0 million, reflecting strong growth; secured a five-year A$44 million contract with Advanced Radiology Management for Visage 7 Enterprise in November 2025; signed multiple multi-year contracts in prior periods, such as a nine-year US$33 million partnership with the University of Kentucky; launched Visage Ease VP for Apple Vision Pro in February 2024; and continues to pursue mergers and acquisitions as stated by its chairman in November 2025.
Company News
Pro Medicus (OTCMKTS:PMCUF) versus DarioHealth (NASDAQ:DRIO) Head to Head Survey
Pro Medicus Limited (PMDIY) Q4 2026 Earnings Call Transcript
Firefly Neuroscience (NASDAQ:AIFF) vs. Pro Medicus (OTCMKTS:PMCUF) Head-To-Head Analysis
Pro Medicus Limited (PMDIY) Q2 2026 Earnings Call Transcript
Insider Buying: Pro Medicus (ASX:PME) Insider Acquires A$134,400.00 in Stock
Pro Medicus (OTCMKTS:PMCUF) Shares Down 4% – Time to Sell?
Pro Medicus Limited (PMDIY) Shareholder/Analyst Call Transcript
Pro Medicus Limited (PMCUF) Q4 2025 Earnings Call Transcript
Pro Medicus Limited (PMCUF) Q2 2025 Earnings Call Transcript
Pro Medicus Limited (PMCUF) Q4 2024 Earnings Call Transcript
Pro Medicus Limited (PMCUF) Q4 2023 Earnings Call Transcript
Pro Medicus Limited (PMCUF) Q4 2023 Earnings Call Transcript
Pro Medicus Limited (PMCUF) Q2 2023 Earnings Call Transcript
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q4 2022 Results - Earnings Call Transcript
Pro Medicus Limited (PMCUF) CEO Sam Hupert On Q2 2022 Results - Earnings Call Transcript
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Half Year 2022 Results - Earnings Call Transcript
Pro Medicus' (PMCUF) CEO Sam Hupert on Q4 2021 Results - Earnings Call Transcript
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q2 2021 Results - Earnings Call Transcript